Show simple item record

dc.contributor.authorVarley, Jennifer
dc.contributor.authorAttwooll, Claire L
dc.contributor.authorWhite, Gavin R M
dc.contributor.authorMcGown, Gail
dc.contributor.authorThorncroft, Mary R
dc.contributor.authorKelsey, Anna M
dc.contributor.authorGreaves, Martin J
dc.contributor.authorBoyle, John M
dc.contributor.authorBirch, Jillian M
dc.date.accessioned2009-11-06T10:52:55Z
dc.date.available2009-11-06T10:52:55Z
dc.date.issued2001-05-10
dc.identifier.citationCharacterization of germline TP53 splicing mutations and their genetic and functional analysis. 2001, 20 (21):2647-54 Oncogeneen
dc.identifier.issn0950-9232
dc.identifier.pmid11420676
dc.identifier.doi10.1038/sj.onc.1204369
dc.identifier.urihttp://hdl.handle.net/10541/85501
dc.description.abstractGermline TP53 splicing mutations have been described infrequently (>2%) in the literature, however in a series of 40 patients and families identified by our group in which there are germline TP53 mutations, seven affect splicing (18%). The low figure reported in the literature might reflect the method of mutation detection, which in many studies does not include all splice junctions. These data indicate that a significant proportion of TP53 germline mutations are currently unrecognized. We have carried out detailed studies of the effects of the different mutations on splicing, and see distinct variations in the effects of the same mutation in different patients. Furthermore we have identified the usage of a non-consensus splice donor site in four families with an intron 4 splice donor mutation.
dc.language.isoenen
dc.subjectTumour Suppressor Protein p53en
dc.subject.meshAlternative Splicing
dc.subject.meshCell Line
dc.subject.meshFibroblasts
dc.subject.meshGenes, p53
dc.subject.meshGerm-Line Mutation
dc.subject.meshHumans
dc.subject.meshImmunohistochemistry
dc.subject.meshIntrons
dc.subject.meshLi-Fraumeni Syndrome
dc.subject.meshLoss of Heterozygosity
dc.subject.meshLymphocytes
dc.subject.meshNeoplasms
dc.subject.meshReverse Transcriptase Polymerase Chain Reaction
dc.subject.meshTumor Suppressor Protein p53
dc.titleCharacterization of germline TP53 splicing mutations and their genetic and functional analysis.en
dc.typeArticleen
dc.contributor.departmentCRC Cancer Genetics Group, Paterson Institute for Cancer Research, Wilmslow Road, Manchester M20 4BX, UK.en
dc.identifier.journalOncogeneen
html.description.abstractGermline TP53 splicing mutations have been described infrequently (>2%) in the literature, however in a series of 40 patients and families identified by our group in which there are germline TP53 mutations, seven affect splicing (18%). The low figure reported in the literature might reflect the method of mutation detection, which in many studies does not include all splice junctions. These data indicate that a significant proportion of TP53 germline mutations are currently unrecognized. We have carried out detailed studies of the effects of the different mutations on splicing, and see distinct variations in the effects of the same mutation in different patients. Furthermore we have identified the usage of a non-consensus splice donor site in four families with an intron 4 splice donor mutation.


This item appears in the following Collection(s)

Show simple item record